<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01828801</url>
  </required_header>
  <id_info>
    <org_study_id>10017</org_study_id>
    <nct_id>NCT01828801</nct_id>
  </id_info>
  <brief_title>Pinnacle Metal-on-Metal 522 Post-Market Surveillance Study</brief_title>
  <official_title>Cross-Sectional, Multi-Center Evaluation of 8 Year Metal Ion Trends for Pinnacle MoM System Used in Primary Hip Arthroplasty</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>DePuy Orthopaedics</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>DePuy Orthopaedics</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this clinical study is to evaluate blood metal ion levels as a function of
      time of implantation for the Pinnacle Acetabular MoM system.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2013</start_date>
  <completion_date type="Actual">August 2016</completion_date>
  <primary_completion_date type="Actual">November 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Chromium serum ion level across time intervals</measure>
    <time_frame>Pre-operatively through 8 years</time_frame>
    <description>To compare the chromium serum ion levels in the patient population from pre-operatively through 8 years post-operatively in a 1-way ANOVA. This is a cross-sectional study so each time interval (pre-operatively through 8 years post-operatively) will be a different cohort of patients.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Chromium whole blood ion level across time intervals</measure>
    <time_frame>Pre-operatively through 8 years</time_frame>
    <description>To compare the chromium whole blood ion levels in the patient population from pre-operatively through 8 years post-operatively in a 1-way ANOVA. This is a cross-sectional study so each time interval (pre-operatively through 8 years post-operatively) will be a different cohort of patients.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Cobalt serum ion level across time intervals</measure>
    <time_frame>Pre-operatively through 8 years</time_frame>
    <description>To compare the cobalt serum ion levels in the patient population from pre-operatively through 8 years post-operatively in a 1-way ANOVA. This is a cross-sectional study so each time interval (pre-operatively through 8 years post-operatively) will be a different cohort of patients.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Cobalt whole blood ion level across time intervals</measure>
    <time_frame>Pre-operatively through 8 years</time_frame>
    <description>To compare the cobalt whole blood ion levels in the patient population from pre-operatively through 8 years post-operatively in a 1-way ANOVA. This is a cross-sectional study so each time interval (pre-operatively through 8 years post-operatively) will be a different cohort of patients.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Poolability of data across stem types</measure>
    <time_frame>Pre-operatively through 8 years post-operatively</time_frame>
    <description>Within each of the primary analyses, the poolability of data across stem types will be confirmed with a 2-way ANOVA model in which both time interval and stem type are independent variables.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of adverse local tissue reaction (ALTR)</measure>
    <time_frame>Pre-operatively through 8 years post-operatively</time_frame>
    <description>To determine trends in the incidence of ALTR over time.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Implant survivorship</measure>
    <time_frame>Through 8 years post-operatively</time_frame>
    <description>To determine implant survivorship, where an implant is considered to be surviving when none of the total hip replacement (THR) system components have been removed or replaced, so that the original system with metal-on-metal (MoM) articulating surfaces remains intact. Implant survivorship will be analyzed in two ways: 1) for all revisions (for any reason) and 2) for revisions due to ALTR.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To identify the incidence of ALTR among unrevised subjects</measure>
    <time_frame>Through 8 years post-operatively</time_frame>
    <description>To identify the incidence of ALTR among unrevised subjects through physical examination and imaging.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ion levels among revised subjects</measure>
    <time_frame>Pre-operatively through 8 years post-operatively</time_frame>
    <description>To compare cobalt and chromium ion level (prior to revision) vs. baseline for subjects who are revised.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Harris Hip and HOOS analysis for pain, function and total score</measure>
    <time_frame>Though 8 years post-operatively</time_frame>
    <description>To identify the incidence of pain or functional symptoms among unrevised subjects with a Harris Hip and HOOS evaluation. To compare cobalt and chromium ion levels for unrevised subject who are exhibiting pain or functional symptoms vs. unrevised subjects who are not exhibiting pain or functional symptoms.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To determine the association of adverse events with elevated ion levels</measure>
    <time_frame>Through 8 years post-operatively</time_frame>
    <description>To investigate the association of adverse events with elevated cobalt and chromium ion levels. For each respective adverse event, to compare cobalt and chromium ion levels for subjects who have vs. subjects who have not exhibited the adverse event. For each respective adverse event category, to present summary statistics of cobalt and chromium ion levels for subjects who have vs. subjects who have not exhibited the adverse event, stratified by post-op time cohort.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Trending</measure>
    <time_frame>Through 8 years post-operatively</time_frame>
    <description>Trends (over time since initial implant) will be evaluated for: 1) revisions (survivorship), 2) adverse events, 3) pain or functional symptoms (via Harris Hip and HOOS evaluations), 4) incidence of ALTR in unrevised subjects</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient history and demographics and association with outcomes</measure>
    <time_frame>Throughout 8 years post-operatively</time_frame>
    <description>Patient demographic and subject history will be evaluated for association with: 1) higher metal ion levels and 2) risk of revision.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Modes and causes of implant failure</measure>
    <time_frame>Through 8 years post-operatively</time_frame>
    <description>To evaluate modes and causes of implant failure based on an analysis of reasonably available explanted retrieved devices.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Metal ion levels and association with reason for revision</measure>
    <time_frame>Through 8 years post-operatively</time_frame>
    <description>To compare cobalt and chromium levels across the different reasons for revision.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Comparison of metal ion levels across subjects with vs. without ALTR</measure>
    <time_frame>Through 8 years post-operatively</time_frame>
    <description>Cobalt and Chromium ion levels will be compared for unrevised subjects who were not diagnosed with an ALTR vs. unrevised subject who were diagnosed with an ALTR.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ion level vs. baseline for ALTR subjects</measure>
    <time_frame>Through 8 years post-operatively</time_frame>
    <description>To compare cobalt and chromium ion level vs. baseline for subject who are diagnosed with ALTR.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ion level change from first measurement for ALTR subjects</measure>
    <time_frame>Through 8 years post-operatively</time_frame>
    <description>Cobalt and chromium ion levels will be compared from first measurement to the time of revision (prior to revision) or the time of last follow-up visit in the study, whichever comes first, for subjects who are diagnosed with an ALTR.</description>
  </secondary_outcome>
  <number_of_groups>9</number_of_groups>
  <enrollment type="Actual">276</enrollment>
  <condition>Pinnacle Metal-on-Metal</condition>
  <condition>Revised Pinnacle Metal-on-Metal</condition>
  <condition>Adverse Local Tissue Reaction</condition>
  <condition>Metal Ions</condition>
  <condition>Total Hip Arthroplasty</condition>
  <arm_group>
    <arm_group_label>Pre-Op</arm_group_label>
    <description>Pre-operative patients who will undergo a total hip replacement.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>1 year post-op</arm_group_label>
    <description>Patients that underwent a Pinnacle Metal-on-Metal (MoM) total hip replacement (THR) and at the time of enrollment, based on their date of surgery, were 1 year post-operative . Alternatively these are patients who have had their Pinnacle Metal-on-Metal hip revised but if they were not revised, would have fallen into this time point.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2 year post-op</arm_group_label>
    <description>Patients that underwent a Pinnacle Metal-on-Metal (MoM) total hip replacement (THR) and at the time of enrollment, based on their date of surgery, were 2 years post-operative . Alternatively these are patients who have had their Pinnacle Metal-on-Metal hip revised but if they were not revised, would have fallen into this time point.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3 year post-op</arm_group_label>
    <description>Patients that underwent a Pinnacle Metal-on-Metal (MoM) total hip replacement (THR) and at the time of enrollment, based on their date of surgery, were 3 years post-operative . Alternatively these are patients who have had their Pinnacle Metal-on-Metal hip revised but if they were not revised, would have fallen into this time point.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>4 year post-op</arm_group_label>
    <description>Patients that underwent a Pinnacle Metal-on-Metal (MoM) total hip replacement (THR) and at the time of enrollment, based on their date of surgery, were 4 years post-operative . Alternatively these are patients who have had their Pinnacle Metal-on-Metal hip revised but if they were not revised, would have fallen into this time point.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>5 year post-op</arm_group_label>
    <description>Patients that underwent a Pinnacle Metal-on-Metal (MoM) total hip replacement (THR) and at the time of enrollment, based on their date of surgery, were 5 years post-operative . Alternatively these are patients who have had their Pinnacle Metal-on-Metal hip revised but if they were not revised, would have fallen into this time point.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>6 year post-op</arm_group_label>
    <description>Patients that underwent a Pinnacle Metal-on-Metal (MoM) total hip replacement (THR) and at the time of enrollment, based on their date of surgery, were 6 years post-operative . Alternatively these are patients who have had their Pinnacle Metal-on-Metal hip revised but if they were not revised, would have fallen into this time point.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>7 year post-op</arm_group_label>
    <description>Patients that underwent a Pinnacle Metal-on-Metal (MoM) total hip replacement (THR) and at the time of enrollment, based on their date of surgery, were 7 years post-operative . Alternatively these are patients who have had their Pinnacle Metal-on-Metal hip revised but if they were not revised, would have fallen into this time point.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>8 year post-op</arm_group_label>
    <description>Patients that underwent a Pinnacle Metal-on-Metal (MoM) total hip replacement (THR) and at the time of enrollment, based on their date of surgery, were 8 years post-operative . Alternatively these are patients who have had their Pinnacle Metal-on-Metal hip revised but if they were not revised, would have fallen into this time point.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Pinnacle Metal-on Metal</intervention_name>
    <description>All patients that are post-operative will have undergone total hip arthroplasty with the Pinnacle Metal-on-Metal device</description>
    <arm_group_label>1 year post-op</arm_group_label>
    <arm_group_label>2 year post-op</arm_group_label>
    <arm_group_label>3 year post-op</arm_group_label>
    <arm_group_label>4 year post-op</arm_group_label>
    <arm_group_label>5 year post-op</arm_group_label>
    <arm_group_label>6 year post-op</arm_group_label>
    <arm_group_label>7 year post-op</arm_group_label>
    <arm_group_label>8 year post-op</arm_group_label>
    <other_name>Pinnacle MoM</other_name>
    <other_name>Ultamet</other_name>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Whole blood and serum samples are retained.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients that have undergone a total hip arthroplasty with the Pinnacle Metal-on-Metal
        device within the past 8 years.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Able to (or capable of) provide written, voluntary consent to participate in the
             clinical investigation

          2. Is willing and able to return for all protocol defined clinic visits

          3. Subject has a combination of the following implants in the study hip (unless in pre-op
             cohort):

               1. Pinnacle acetabular shell with or without Gription TM porous coating

               2. M-specification cobalt-chrome femoral head or aSphere M-specification
                  cobalt-chrome femoral head

               3. Ultamet metal insert

               4. One of the following stems

             i. S-ROM ii. Corail iii. Tri-Lock iv. AML v. Summit vi. Prodigy vii. C-Stem

          4. Subject has high quality films available for review that were taken within 12 months
             of the primary surgery of the following views:

               1. Standing AP-Pelvis

               2. Standing AP-Proximal Femur (if this view is not available but the AP-Pelvis shows
                  the entire implant and greater trochanter, that is also acceptable)

               3. Lauenstein Lateral Proximal Femur (Lateral-Femur)

        Exclusion Criteria:

          1. The subject refuses to allow their medical records to be inspected by the Sponsor,
             representatives of the Sponsor, the medical office staff and/or representatives from
             FDA

          2. The implanted hip components in the study hip (exclusive of cement), are not all DePuy
             components (unless in pre-op cohort)

          3. The primary procedure occurred greater than 8 (eight) years ago (unless in pre-op
             cohort)

          4. FOR PRE-OPERATIVE COHORT ONLY: the subject has a MoM contralateral hip

          5. FOR PRE-OPERATIVE COHORT ONLY: the subject is undergoing a revision of the Ipsilateral
             hip
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mary F Panozzo, BS</last_name>
    <role>Study Director</role>
    <affiliation>DePuy Synthes Joint Reconstruction</affiliation>
  </overall_official>
  <location>
    <facility>
      <address>
        <city>Orange</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Fort Collins</city>
        <state>Colorado</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Lone Tree</city>
        <state>Colorado</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Syracuse</city>
        <state>New York</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Charlotte</city>
        <state>North Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Cincinnatti</city>
        <state>Ohio</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 2, 2013</study_first_submitted>
  <study_first_submitted_qc>April 8, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 11, 2013</study_first_posted>
  <last_update_submitted>September 23, 2016</last_update_submitted>
  <last_update_submitted_qc>September 23, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 26, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Adverse Local Tissue Reaction</keyword>
  <keyword>Metal Ions</keyword>
  <keyword>Serum</keyword>
  <keyword>Whole Blood</keyword>
  <keyword>Metal-on-Metal</keyword>
  <keyword>Total Hip Arthroplasty</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

